First-time generic approvals
Potassium iodide oral solution 65 mg/mL
Potassium iodide oral solution 65 mg/mL (equiv to Thyrosafe tablets 65 mg)
FLEMING & COMPANY
Terconazole vaginal cream 0.4% (equiv to Terazole 7 Vaginal Cream)
TARO
Estradiol transdermal system 0.025 mg/d and 0.075 mg/d (equiv to Climara)
MYLAN
Levofloxacin tablets 750 mg (equiv to Levaquin tablets)
TEVA
Desmopressin nasal solution 0.01% (equiv to DDAVP nasal spray)
APOTEX
Fentanyl transdermal systems 25 mcg/h, 50 mcg/h, 75 mcg/h, and 100 mcg/h (equiv to Duragesic transdermal systems)
MYLAN
Employers Face Barriers With Adopting Biosimilars
March 1st 2022Despite the promise of savings billions of dollars in the United States, adoption of biosimilars has been slow. A roundtable discussion among employers highlighted some of the barriers, including formulary design and drug pricing and rebates.
